Stock page
Ludwig Enterprises Inc (LUDG)
Ludwig Enterprises Inc is an early-stage genomic technology company focused on developing screening tests for inflammation-related chronic diseases, including cancers. Its platform integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits designed to provide a differentiated and patient-friendly approach to cancer screening. The company's business model combines a business-to-business-to-consumer (B2B2C) approach with partnerships through CLIA-certified laboratories. It is focused on offering home collection kits directly to patients, supported by certified genetic counselors, while also enabling independent laboratories to provide the Revealia Breast test (Ludwig's key product candidate) as a Laboratory Developed Test (LDT).
Quote snapshot
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|